glp-1 stomach paralysis class action in louisiana woman sues drug makers of Ozempic and Mounjaro over 'stomach paralysis' glp-1 gastric stasis lawsuit in

This unified pathology validates the complex, multisystem nature of Long COVID and ME/CFS, proving that these seemingly disparate symptomsburning skin, racing heart, and severe fatigueare all stemming from the same underlying neurological damage

6 Heart Issues This can manifest as arrhythmias or palpitations, with a sensation of an abnormal or rapid heartbeat without an obvious cause

In 2022, a new drug called Tirzepatide sold under the brand name Mounjaro was approved by the FDA

Lilly and competitor Novo Nordisk (NVO) are the duopoly controlling the current GLP-1 market, and there is more demand than the companies combined can supply

Millions of people will lose Medicaid coverage across the country," Shih said

In this approach, the injection is administered subcutaneously into the abdominal fat, about an inch or two away from the navel